Webinar

About this Event:

Webinar Title: Visualizing in 3D: True Spatial Sequencing to Accelerate Stem Cell-Based Therapeutics and Discoveries

Hosted By: Elsa Molina, PhD, Stem Cell Genomics Core Director, Sanford Consortium for Regenerative Medicine, UC San Diego

Date: Thursday, October 22, 2020

Time: 12:30 – 1:30 PT /3:30 – 4:30 PM ET

Access this Webinar:

https://us04web.zoom.us/j/73778032438?pwd=Q1lkOThxRG16ZmhMNktsQmNMRER1UT09

PassCode: ReadCoor

Webinar Abstract: True multi-omic spatial sequencing is a powerful technology for research and discovery applications. The ability to multiplex detection of tens to thousands of genes and combine measurements of RNA, DNA, proteins, and therapeutics in single cells within the native 3D tissue organization will enable applications ranging from basic research to clinical tests. In this presentation, learn how ReadCoor’s RC2 Platform can be utilized to visualize all molecules with sub-cellular nanoscale resolution in every cell throughout any tissue section. This platform, based on ReadCoor’s proprietary Fluorescent in situ Sequencing (FISSEQ) technology, combines the massive multiplexity of next-generation sequencing (NGS) and high-resolution tissue imaging to revolutionize clinical research and therapeutic development to improve human health.

Speaker:

Samuel A. Inverso, Ph.D.
VP, Global Partnerships
ReadCoor

Sam Inverso stands in front of a wall in the conference room for a photo. He has one hand on his chin and is wearing a white button-up shirt with a gray linen jacket.

Samuel Inverso is an interdisciplinary leader with more than eighteen years of experience in technology and life sciences with a demonstrated history of success. Sam has formed and run cross-functional teams of molecular biologists, software engineers, and bioinformaticians in large scale multi-year projects. He has overseen more than $30 million in funding from pharma, universities, and the federal government. Sam excels at building and communicating strategic frameworks that bridge science and business objectives. At ReadCoor, he is engaged in corporate and business development. He manages collaborations with pharmaceutical and research institutes, including a Bill & Melinda Gates Foundation award and partnership with WAVE Life Sciences.

Prior to being a founding team member of ReadCoor, Sam was a Staff Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss, he contributed to analysis algorithms and bioinformatics for Fluorescent in situ Sequencing and is a co-author of the seminal 2014 Science paper. In addition, he was co-PI (with George Church) on a multi-million-dollar multi-year IARPA MICrONS project to use FISSEQ to map the neural circuits of a mouse brain at the synaptic level. The role included managing a large team of staff, postdocs, graduate students, and research assistants in interdisciplinary fields from molecular biology and engineering in a large consortium that included MIT, CSHL, and Columbia.

Sam received his Bachelor of Science and Master of Science in Computer Science from the Rochester Institute of Technology. He has a Ph.D. in Neuroscience from the Australian National University and Postdoctoral training in Alzheimer’s Disease at the Institut Pasteur.